Medgend Icon







discontinued


Cabometyx FDA Approved Drugs

CABOMETYX [Cabozantinib S-malateC28H24FN3O5C4H6O5]
RX
-
eq 20mg base (oral tablet)
eq 40mg base (oral tablet)
eq 60mg base (oral tablet)
Exelixis IncApr 25, 2016
  • Treatment of renal cell carcinoma.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

COMETRIQ [Cabozantinib S-malateC28H24FN3O5C4H6O5]
RX
-
eq 20mg base (oral capsule)
eq 80mg base (oral capsule)
ExelixisNov 29, 2012
  • Method of treating medullary thyroid cancer.
efficacy
5.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.